Takeda Pharmaceutical Co(GB:0RN3)
€35.200.00 (0.00%)
GB:0RN3
Takeda Pharmaceutical Co earnings date
€35.20
At close:0.00 (0.00%)
Takeda Pharmaceutical Co (0RN3) Q2 2023 Earnings Report
4 Followers
GB:0RN3 Q2 2023 EPS Results
- Actual EPS
- -EUR 0.18
- Consensus EPS
- EUR 0.16
- Beat/Miss
- Missed by -EUR 0.34
- One Year Ago EPS
- EUR 0.23
GB:0RN3 Q2 2023 Revenue Results
- Actual Revenue
- EUR 5.97B
- Expected Revenue
- EUR 5.68B
- Beat/Miss
- Beat by +EUR 283.73M
- YoY Revenue Growth
- +4.07%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 10/26/2023
- Time
- Before Open
- Conference Call
- Thursday, October 26, 2023
GB:0RN3 Upcoming Earnings
Takeda Pharmaceutical Co's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
GB:0RN3 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
GB:0RN3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 0.26- | 0.38 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 0.260.69 | -0.04 | 1643.81% (+0.74) | |
| Jul 30, 2026 | 2026 (Q1) | 0.310.41 | 0.45 | -9.76% (-0.04) | |
| May 13, 2026 | 2025 (Q4) | -0.14-0.09 | -0.38 | 76.42% (+0.29) | |
| Jan 28, 2026 | 2025 (Q3) | 0.250.38 | 0.09 | 333.93% (+0.29) | |
| Oct 30, 2025 | 2025 (Q2) | 0.12-0.04 | 0.33 | -113.45% (-0.38) | |
| Jul 30, 2025 | 2025 (Q1) | 0.280.45 | 0.35 | 30.16% (+0.11) | |
| May 08, 2025 | 2024 (Q4) | -0.05-0.38 | -0.01 | -3042.86% (-0.37) | |
| Jan 30, 2025 | 2024 (Q3) | 0.150.09 | 0.39 | -77.59% (-0.30) | |
| Oct 31, 2024 | 2024 (Q2) | 0.210.33 | -0.18 | 287.77% (+0.51) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


